Autoimmunity and biohacking a path toward health with Mette Dyhrberg

Play Video

Audio Stream

Meet Mette Dyhrberg of Mymee. Using pattern recognition and process optimization — the stuff of good biohackers everywhere — she took her health into her own hands and created a movement to tackle the many challenges of autoimmunity.

This podcast is for educational purposes only. It is not a substitute for professional care by a doctor or other qualified medical professional.

Dr. Jeff Bland:

Well, here I am again, in this extraordinarily exciting opportunity to talk with one of the true thought leaders in our field around this whole topic of immunity. And one has asked me the question, with a podcast, what are the criteria used to select these extraordinary personalities that you interview? And I’d have to say the criteria is to find the most remarkable people who are pace-setters, that see the world in unique ways, that I know, and try to allow them to tell their story. Because there are just amazing people out in this world whose voices and whose insights can transform the health and wellbeing of, literally, millions of people. And I’m fortunate that one of those individuals in that portfolio of criteria is our interviewee of today, and that’s Mette Dyhrberg. So let me just say a couple of words about this extraordinary woman. She is multi-talented, and she has a very strong background in economics and a very strong background in high-level business planning, and then she encountered her own life experience. As they say, life is what happens in between our plans.

And her life experience, that she will tell you about, transformed a lot of her thinking about where she wanted to put her energy and her creativity and her insight, which might be a very, very different place than you would see on her biography, as it relates to her academic background or her resume. But because talented people have multiple ways that they can express their talents, so it was with Mette Dyhrberg and the development of this company, Mymee. M-Y-M-E-E. Which she will tell you about, which I think is a really amazing pace-leading company in the field of immunity and this concept of how immunity transitions itself in the public ID, how it actually can become part of what we all think, act, and do to improve our immune system function, I think is the challenge of the 21st century. And Mymee and its leadership, through Mette Dyhrberg, is advancing this question, this challenge, this opportunity in a very unique way.

Well with that introduction, I think now the key is to bring our personality and introduce you to Mette Dyhrberg who I think you’ll see why she’s a remarkable person and why she is quintessential for the kinds of things that we’re trying to do with Big Bold Health Personalized Immunity Podcast. So Mette, thanks so much for joining us and maybe you can just, as a start, tell us how you got into this interesting transition in your life, in your career, in your focus because I think it’s a wonderful story beyond, of your focus on immunity. So how did you get here?

Mette Dyhrberg:

Yeah. So, what now is an interesting story felt like a personal nightmare for a long time. I got my first autoimmune condition at 14 and spent the first half of my 20s in and out of the ER, in and out of hospitals. And the second half of my 20s, I collected disease labels. So, by 30, I had six autoimmune conditions, was seeing numerous doctors, was heavily medicated, but nothing really helped me. And so I was really setting out to be a chronic patient when in my mid-30s, one of my many doctors told me that they had “great news” and then proceeded to tell me that I wasn’t going to die in the “immediate future.” And I remember that moment in time as if it was sort of like everything stood still because I had called my mom in the car on the way there, told her that stay tuned, there’s going to be good news waiting.

And that was actually the hardest part is how do you call your mom and tell her that that’s the great news? And so at the time, I asked one question, which was what are we going to do about my process? And my doctor barely finished. He looked me straight in the eye and he said we’re happy with your numbers. And I’m an economist by training and to this day I’m forever grateful that that’s what he answered because I knew at that moment that he did not know how to help me. And so I walked out of the hospital and called my parents and said I’m not going back. And clearly today, it seems like that was the right move, but at the time it was disempowered as a patient, but in a way empowered as a human, because I knew I had to get some sort of control.

And so needless to say, I had no idea that I was actually going to be able to find a way out of my situation, but I at least knew that I needed a different way. And so I started with the only thing I knew, which was numbers. And so I started charting everything, journaling, and being an economist. We love Excel spreadsheets. So the first thing you do is you translate them over and then you start noticing patterns. And I also started seeing that, hey, I needed the meta data, I needed the timestamps. So instead, I started texting myself and then I started adding geolocation so I could see if I was feeling different in the different locations that I spent most of my time. And over a period of five months, I was able to identify and back ravel my cardiac issues and I had done weekly EKGs, blood thinners, cholesterol lowers.

If it was meant to my grandmother, I had done it since I was 24. And so I thought to myself wow, it’s so many times when they told me about a new autoimmune development, it was because of your cardiac issues. But if I didn’t have them underlying, maybe I could just get rid of all of it. And so to my sort of luck, I didn’t know much about healthcare. Actually I knew nothing of healthcare. And so I didn’t have any of those mechanisms that says this is not possible or there is all of these obstacles in your way. I basically just naively applied process optimization to my own body. And by looking at my body, as opposed to like a computer system, I identified processes that needed to be tweaked, whether that was by identifying triggers that needed to be removed or beneficiary interventions that were to be added.

It was really sort of an A/B testing process. And 16 months to the date from when I started, I had normalized my blood work, reversed all my disease symptoms, and I’ve been drug- and symptom-free next month for 10 years. So yeah, that was sort of my entrance point into health care. And needless to say, as an entrepreneur, you fix problems. That’s what you do. So when I felt better, I really couldn’t wait to just move on. I just started another company and that was really what I wanted to do. I never intended to go into health care, but I just wanted somebody to see that it was possible. So I showed up with my little computer and said to my doctor’s team, look at this. And first of all, they weren’t really that interested in looking at the data, but they then came to the conclusion that I most likely had not been sick in the first place.

And to me, that was like the biggest insult of all, because I’m home there for 20 years at the time and with declining health over the entire period. And so at the… I guess as an entrepreneur, you make quick decisions. So in my head I thought I’m a foreigner with a lot of preexisting conditions. My premium is through the roof. So I took out my hand and I said I’ll take that deal. And the doctor goes what deal? And I said you just told me it was all in my head, which means that it would go off the EHR. Right? And he goes oh, no, no, no. Because of your, I had a non-alcoholic fatty liver, I had organ involvement, all sorts of things. He’s like there’s no way we can take it off the EHR. And I remember thinking that’s like just the… You just showed me what? And it’s the first time I’ve ever used this expression, but like a shit sandwich. There was absolutely no win for me in this.

And so I started thinking about this day and night. And then a couple of months later, Kevin Kelly, who at the time was senior editor at Wired magazine, started something called Quantified Self, which really was self knowledge through numbers. And so I spoke at the very first one in New York and it became family. It was a bunch of biohackers that were obsessed about their bodies and about how we could intervene through these in essentially biological experiments on yourself. But there was some fundamental different in the sense that a lot of them loved data. They were obsessed with this idea of more data. I was obsessed with the idea of asking the right questions. And to the outside of that might be two sides of the same thing, but I think getting more data, if you don’t gain more insight is invaluable.

And for an autoimmune patient, life is like that rope in gym class. You put it into motion and even when you let go, it just keeps sort of going and your life will always feel like it’s out of your hands. I gave a speech once around how I was a professional boxer, because I feel like I’m shadow boxing 24 hours of my life. Nobody tells me when the match is on, but there’s definitely going to be a match and you have to be ready for it. But that powerlessness of being a patient is really one of the hardest things to grasp. And your immune system, unfortunately not always gives you warnings that we as humans know how to read. We have now, working with people for the better part of a decade, and we now can say things like that little scratch on his throat, that’s a 13-hour notification that you’re going to go into ketosis or that little, whatever it is, that’s actually the sign that you haven’t gotten sleep or you’ve done a little bit too much of this or that.

But getting people that blueprint that allows them to reclaim their health because now they know exactly what works and doesn’t work for them is sort of what we set out to do. And in many ways, autoimmunity as you know, there’s no one size fits all. It’s definitely not like if you’re a lupus patient, take this little booklet and follow steps one to 10 and then you’ll be fine. It’s more sort of a crash course in how do we best read you and what goes into the formation of this disease for you particularly? And it’s been a fascinating journey but it’s also been fascinating to see that what I considered within the realm of my control versus what was sort of happening to me in that line has completely moved because I know today that whether it’s my mood, my intelligence, my gumption, my intuition or intellect, depending on how you look at it, it actually always come down to things that I can control, but I just never, never knew how to read my body that way prior to all of this sort of coming together.

Dr. Jeff Bland:

There’s so many things that you’ve touched on that are extraordinarily insightful and important. I want to take a little time to unpack some of these ideas because I think there’s a lot of density in your words in terms of information that individuals can value from. So the first thing that hits me obviously is you are the quintessential citizen scientist. And we have a move that’s occurring in the country right now of people, partly as a consequence maybe of the open nature of information shared on the internet. Now people are taking looks at themselves using a different lens than they used to and less accepting what people tell them and more interested in finding out for themselves that citizen scientist concept and this biohacker movement and the quantified-self movement that you talked about, Michael Snyder at Stanford, who is one of the leaders in the medical world on this.

These are places where people can self recruit. It takes a certain type of courage to do that though and it takes a certain type of motivation. But not everybody that has an auto-immune disease maybe is motivated. So I think when you put my need together as a company that allows your motivation then to be spread over others who may be not quite able to manifest the same degree of vigilance and initiative you did, it sets the opportunity then for the group process to share this quantified-self principle across many, many others. And I think what you’re starting to see with Mymee is making this more accessible, your learning curve, which not everybody can probably incorporate within their lives. You’ve made it… You kind of pioneered the way to make it more easy to be implemented for others in the Mymee. So you might tell us how then your experience then transitioned into formation of Mymee as a way to generalize this for other individuals.

Mette Dyhrberg:

Yeah. So I think a lot of the learnings initially really came from this notion that autoimmunity, at the time, was seen as these 80 to 100 different autoimmune diseases based on where the body was being attacked. We were fundamentally asking a different question, which is why. And so, as we were starting to unravel sort of the underlying issues for why people’s systems were overreacting and attacking themselves, we started seeing patterns that were more to the fact that just because you have a complicated problem, it doesn’t necessarily mean you need a complicated solution. So we really started simplifying things and continuously honing in on what would be sort of the lowest hanging fruit. What is that little thing that you can do that might do a little bit of a difference, but for somebody who hasn’t felt like themselves for decades, in some cases, anything that can bring them just to tap it closer to who they used to be, they’ll trust.

So from our perspective, it came down to understanding how can we make somebody feel benefit in their life? And when I say benefit, I don’t mean something that gets measured in blood work or something that they can see next month from their lab report, but really a benefit. You can go and pick up your kids from school, you can cook dinner, and you would not believe how many women are lying around in bed dreaming of cleaning the house. You think people have different aspirations, but I think we all want to be useful. We want to play a role in our family’s life. And so what we’ve understood very early on was we needed to make it super easy and so we needed to make it matter. And in order for something to matter, it has to be something that you can deeply relate to.

So one of the things that early on was a big item in sort of the self-tracking movement was how depressed are you from one to five? And if you’re like depressed all the time, you’re actually just getting more depressed. And so we were very early, very sort of aware that we needed to find ways to help people that didn’t actually focus on their shortcomings, but really focus on their wins. And to this day, every coach call that is internally happening at Mymee start with client wins because that’s what we fuel ourselves with and that’s what we fuel the clients is actually understanding how can we make you win this game of you because you can feel like yourself again? And so that was really the most important part.

And some of the technology that we’ve implemented today is patents around translational. So we don’t use medical language. We translate it into your language. And we did a study with Cornell and chronic pain recently and I think it’s such a good example because they wanted mild, moderate, severe pain. And some people have been in car crashes and some people had RA. And you’re like okay, this is apples and pears. But when you actually spend a little bit of time with the individual, the person with RA will say achy joints, mobility issues, I can’t get out of bed. And to that individual, I’ve never met anyone who didn’t know when they could get out of bed. So it’s very precise, but it also means that you can take out your phone, press a topic and you’re done. So it only takes a couple of minutes a day to use Mymee, which is really the equivalent of what it takes to use an electric toothbrush.

And we see ourselves a little bit like that, that we are an adjunct therapy. So for a rheumatologist, so gastroenterologist, we are what the electric tooth toothbrush is to the dentist. We are sort of that intervention that can help people provide some self care that they might have dreamed off, but they couldn’t pinpoint exactly what that looked like for them.

Dr. Jeff Bland:

Yeah. I see it. What you’re saying there is brilliant and this is where the genius of people’s creativity starts to demonstrate itself. What you’re saying is you can help a person become their own citizen scientist about their own body through very small iterative steps that have to do with taking information in and being conscious about how you’re recording your daily experience and that journaling, that kind of acknowledging how your day is going and how it connects to things around you is such a powerful concept, but it needs to be made very simple and kind of effortless, like maybe your analogy with the electric toothbrush to make a proper oral hygiene more practical. And I think that this construct that you’ve developed, it reminds me of an experience that I had that was actually a frameshifting experience when I was running the Functional Medicine Clinical Research Center in Gig Harbor, Washington.

And one day, one of our physicians came into my office in the morning and he was quite upset, Dr. Jack Kornberg, and he dropped the local newspaper on my desk and said I’m really disgusted. Look at this article in the newspaper. It was on the cover of the second section in the newspaper. And it was a photograph of a pair of hands and in the hands were a whole series of pills. And the story was about a woman who had this unique autoimmune condition, erythromelalgia, in which she was being treated at a local medical school hospital by top rheumatologists. And she was still at a fairly young age, a mother of four children, pretty much incapacitated. And she was saying that this was a very discouraging for her that she was taking all these medications that were managing her symptoms, but her symptoms were still very, very severe and she was pretty much disabled.

And so Dr. Kornberg said, he says, Jeff, we can help this woman. And I said well, Jack what do we know about this specific form of autoimmune disease, erythromelalgia? It’s not that common. And he said, well, I don’t think we know. We’re not a specialist in that condition, but we know a lot about what it is that people have happen in their lives that creates a disturbance in their immune system that translates into these diseases. Just like you were saying, that it’s not disease centric, it’s environment centric and how that person’s genes connect to their lifestyle and their environment. And he said I think we can help this woman. And I said well, what, what would you propose? He said I would propose it that I call her up and see if she would like to come in to be one of our research subjects. She would still see her traditional physician at the medical school and so forth, but we might be able to provide adjunctive help.

So that started this relationship with her, Anita, I’ll call her. And that I recall the first time that she came in with her husband and parked in our parking lot because the parking lot was right in front of my office. I could see her coming in very labored, walking with him helping her into our office. And the bottom line, I’ll just cut through the story, a year later, after being involved in management by our clinical team, including Dr. Deanna Minich and Dr. Jack Kornberg and Barb Schiltz and others in our clinic, this same woman who had three wishes when she came to us. 

Wish number one is that she could stand at her kitchen counter and produce a meal for her children, which she couldn’t do, because she couldn’t stand long enough to do that. Number two, that she could go out in the spring and plant her garden. She hadn’t been able to go outside successfully for some time. And number three, that she could go to the mall and walk the mall with her kids and get some new shoes. Those were her three wishes. It seemed pretty simple, but for her, they were probably very, very challenging.

Mette Dyhrberg:

Blue sky is very different depending on where you’re looking at the sky from.

Dr. Jeff Bland:

That’s exactly right. And so what happened was a little over a year later… Oh, actually it was about 15 months later. Not only had she, by that time, succeeded in achieving those three wishes, we called them her magic wand wishes, but actually the most remarkable thing was that she came in with her husband. This would have been June. So the starting of the summer season and now she’s walking briskly, not needing assistance. And she has something in her hands and her arms that she has and wrapped up. It’s a gift she wants to give Dr. Kornberg and Dr. Minich. And when it’s opened up, it’s a large framed photograph of her at the top of Mount Si, which is a fairly significant sized mountain outside of Seattle Washington. There is a trail that goes to the top. It’s pretty steep. And here she is at the top of Mount Si, having gone up there with her family on her own power, holding up a sign saying thank you Dr. Jack and Deanna.

And it brought tears to the whole clinical staff, all of us, but it was an example of exactly what you’re saying. And by that time, she had pretty much discontinued all of these medications that she was holding in her hands at the beginning of this whole thing. She was I think almost completely pharmacy free by that time and self-regulated. So that made me an absolute believer of what you’re saying. And it was all part of her engaging in ownership of her health and learning the tools that were required. The things that you’re talking about that you have so personally, successfully implemented, but now have generalized that and making it accessible to so many others. So I just want to say we champion what you’ve done and it is to me, it will not take away every case of autoimmune in the country, autoimmune disease in the country, but this concept that you’re pioneering can significantly help restore people’s immune ownership, ownership of their immune system and start to tame that immune system that’s kind of gone rogue and fighting back.

Mette Dyhrberg:

No, and I also think to your point, people come in and they have these seemingly small dreams, whether it’s cooking or cleaning or other things. Once they come out on the other side, nobody talks about the health anymore. So four out of 10 people on long-term disability go back to work after Mymee. And so one of the things that we get is these letters from women saying thank you so much. I can now buy new sneakers for my teenage sons. Because health is something we take for granted, unless we don’t have it, right? So I think to a large extent, what is interesting here is that autoimmunity has been seen as this very fragmented thing, but we’ve actually today been able to reverse disease symptoms for 67 of the 88 different autoimmune diseases. So there is more.

When you sort of think of health care, generally you have like the median and this is how we like it, one solution. And then you take the outliers away because they sort of mark the picture, but imagine that you saw 1,000 outliers. They’re going to look lot more alike than different. And so at some point, you start being able to use that N-of-one, when you have enough of them placed next to each other, you start getting insights that allow for you to get there faster. And so for us, that means that we can now in medical literature, read certain things. But when I look at the data that we’re getting out of the patients, we get insights that we can’t even find anywhere on the internet or elsewhere. And that’s what’s fascinating to me because I think that we’ve gotten an enormous amount of the way, the sort of the traditional metrics of health.

But when you go to your doctor, it’s sort of a snapshot in time, whether it’s lab work or otherwise, but we live our lives between those doctor’s visits. And that’s actually when the rollercoaster is happening. And so for us initially, it really comes down to being able to help people understand what goes into these things. We have so many people that go on these 60 milligram prednisone stints every four to eight weeks. And as you can imagine, back to sort of that rope that you get into motion, that means your body is never in your control. It’s always sort of going like that and getting that sense of control where you are actually the one who’s able to be in the driver’s seat of your own life, that’s what we want to do.

Dr. Jeff Bland:

Yeah. I think that that is so powerful and this concept of can we own our immune system? And we say, well, that’s… Come on. I mean, it’s our immune system. Of course, we own it, but I’m talking about our self-regulation of our immune system, not allowing the immune system to kind of run wild. But to say, let us be friends with our immune system and create the environment that that immune system needs to be harnessed in a way that produces outcome called good immune defense without injury or I guess a collateral damage to your own body, which is what we see with an immune system that’s over responding or hyper responding to its environment. And so it’s making our immune system into our friend basically and you do that so beautifully.

Mette Dyhrberg:

And I think that’s actually, maybe I should even explain what it consists of because the Mymee program, it’s a clinically validated protocol that has been proven to reduce the disease symptoms in more than 90% of our members. But what it really comes down to is a very basic approach that consists of three key elements. First, this easy-to-use mobile app with the snap-to-track feature. So whether you take a picture of what you eat or it’s a runny nose or joint pain, it’s tailored to you. So you tap and that’s it. But then we take your body signaling and we turn that noise into understanding by pinpointing the causality between what you do and how it affects your symptoms using proprietary technology. And to point earlier, studies have shown that 80% of the immune system comes down to determined by lifestyle and environment, right?

So last but not least, we take certified health coaches are the ones leading the process and they’ve all been reversed their own autoimmune disease so they truly know what it means to walk in your shoes, and they can translate these machine insights into a personalized plan. So through these weekly one-on-one sessions, they will help you avoid triggers, but through these small doable changes that are made over time. So Mymee’s technology can identify triggers in as little as eight weeks, whereas the traditional approach can take years. And I think that’s the key is that we’re able to actually, through these very small things, be able to make a big thing in people’s lives. And, yeah.

Dr. Jeff Bland:

Yeah. I know that you are. I’ve seen the results with people that your program has delivered. It’s absolutely spectacular. And in fact, you might want to even mention you’ve got some colleagues now, some in your medical side of your consulting and work who have leadership in their own respects who have had their own personal experience that, as you said, there’s nothing like personal experience to make you a believer and to make you a good coach and guide. And I’m thinking of two of your colleagues who are just remarkable leaders in their field whose own experience they brought in and are making them even better teachers within your program.

Mette Dyhrberg:

Yeah. No, it’s true. I’m also thinking about Dr. Nicole Bundy who went through your Functional Institute of Medicine, because when I originally, I got introduced to her through Nate at Cleveland Clinic and I had been looking for a chief medical officer for a while at the time and nobody really fit the bill, and Nate called me and he goes I just met someone. I think it’s the right person. And within 45 minutes of talking to Nikki, I was like wow, she has exactly that combination that we need because she’s a traditionally trained Yale rheumatologist, but she had encountered her own autoimmune journey and realized that what she was offering for her clients wouldn’t help her. And so went down sort of the path of exploration, went through the Institute of Functional Medicine, really went through a lot of sort of the work that needs to be done to really understand what it takes in…

And when she came into Mymee, I think we all forgot how much we actually knew at the time, because I think she came in thinking that oh, this is going to be sort of a continuation of what she already knew. And it took a while to sort of wrap your head around a completely different world, but oh my, has she? And it’s been also fascinating to see how even her with all of the knowledge that she’s had in her personal journey, that she’s been able to, through the use of having somebody else sort of pinpoint your blind spots, could get to that equilibrium where your disease is non-existing in your day-to-day. Does that mean we don’t have our diagnosis labels? No. But there’s a big difference between being symptom free versus managed because I think that’s where a lot of us felt like it didn’t really do what we were hoping to.

Dr. Jeff Bland:

Yeah. I think that that’s really, really of an important differentiation. Manage means maybe suppressing symptoms while the condition is still moving forward versus the upstream kind of intervention that’s really treating the downstream signals without having to block the signals. You’re just influencing the system in such a way that the immune system is at rest. And I think that that is really a very big payoff. And Dr. Bundy, by the way, Nicole Bundy is just a remarkable example of a high-level professional at the seat of high academic medicine at Yale and board-certified rheumatologist who through personal experience and an open mind. And I think that’s another thing. You have to have an open mind, open spirit to look at what alternatives might actually be accessible to you and be willing to accept those and not push them away just because your training might have said something else.

And to watch her take her extraordinary training and background and expertise and then convert it into this model and bridge the gap between these two worlds very successfully is, I think, exemplary as well as kind of a great role model for all of us. And I actually think of another person you’re familiar with that has done this and is a pioneer in our field, Dr. Terry Wahls. And I can remember when Dr. Wahls, I think, first came to a seminar I was giving many years ago on autoimmunity, and I believe at that point she was in a wheelchair. And we look at where she is now as this very high performing leader in our field with this whole concept of how to manage MS and other neuromuscular autoimmune conditions, we know it works. We can see it in her. We can see it in the impact that she’s had the field.

So there is some truth in all of this that for some reason hasn’t yet been projected into the body politic of traditional interventional medicine. And I don’t know exactly why that is, but I really celebrate people like yourself who are proving that this model is more than just talk. It really delivers value to people. Why do you think there’s been a resistance in the traditional medical world to accept some of these concepts as being real?

Mette Dyhrberg:

It’s too good to be true. The reality is when you are sick, you get into a smaller and smaller world and you are told that this is the only thing we can do for you and then you get a prescription or something. And for every single, I always talk about the hope bank. When you start out with a big fat hope bank and for everything that you try that doesn’t work, your will sort of shrinks. And at the end, very few people actually believe that anything will work. And so when you tell them that simple things they do on an everyday basis could be the reason, there’s two things in play: One, it can’t be that simple. And for many also, they can’t live with the fact they “did it” to themselves.

And if you think about that, it makes complete sense at a human behavior level, but it doesn’t really explain why we are so resistant to new and, I don’t know if we would call the new, what the word is for what we do actually, but the reality is that I think that we are seeing a tremendous shift with COVID and with the world sort of being in a very different place today than it has ever been. People are more aware of their sort of silent body state needing to be stronger than ever before. And having worked a lot with the COVID long haulers in this past year, for many it’s an acceleration of a pre-autoimmune condition that was dorment, and it’s been fascinating for us, obviously from research perspective. Sometimes you’re almost sad to say, but some of these things can be extremely helpful, right? Because we staged autoimmunity early on. So similar to cancer from zero to four, where a positive A&A but still asymptomatic is a state zero. Then you become symptomatic, but you’re preclinical in stage one.

And then once you get your first clinical diagnosis, you’re stage two. Multifactorial, stage three. And once you have organ involvement or failure, then you’re in stage four. But it allowed for us to say somebody walking in with 30% kidney function, stage four, we could pull back to a stage two and it allows for us from a research perspective to be really clear in our communication around where people were and where they landed. But to be fair, people don’t sign up for things like Mymee unless they’re in that stage two to four. So we had a very good foundational piece in sort of the latter part of, but we didn’t have a lot in the pre-autoimmune. And so with COVID, when Mount Sinai reached out to us in May of last year, we really got that front end of our autoimmune spectrum.

And so for us now, we, we know exactly that the order of events is exactly as we had predicted, but we didn’t have enough bodies through before to prove it. So COVID has really helped a lot of the autoimmune patients that we see get to a faster result because we now know the stacking order.

Dr. Jeff Bland:

Yeah. I think that this long haul COVID is a transforming event in our culture right now. And I just read this New England Journal of Medicine kind of review about really the impact that this is going to have on the whole healthcare system as we move forward with something like maybe 15 million people having different degrees of frequency, duration, and intensity of long COVID symptoms. And if you think of that, those people entering into our healthcare system in which there is really no good way with traditional drug-based pharmacotherapy to manage the complexity of these conditions. They are varied in their presentation. It’s going to require an entirely different model. And this model that you developed and are pioneering is a model that can deal with the complexity of how these immune dysfunctions, I call them immune scars, that come as a result of a SARS-CoV-2 infection, how they can be healed.

And I think that your model is a model that’s more focused in on the, what I call the upstream cause and the downstream symptoms. Because if you’re trying to chase the elusive symptoms with drugs to treat each symptom, you’re never going to be successful in managing the complexity of the long haul COVID symptoms. So I think you’ve really got your arms around something that is at the right time, the right place and the right need.

Mette Dyhrberg:

No, there’s no doubt that when we are looking at the world for this lens of simplicity, then all of a sudden, a lot of things are possible that weren’t possible before. And I think one of the things that I sometimes think about is when we are thinking about this sort of digital evolution, traditionally it was diabetes, right? It made sense because you go to hospital, diabetes didn’t really belong anywhere. It was in every department they were seeing diabetes. And there’s a known causality. BMI, insulin, A1C. So it made for the perfect first sort of technology endeavor. You could translate it into technology, prove out results because there’s clear casualties and the noise was easy to read with all the death comes and whatever was available.

But what we are doing is really sort of a new frontier in health, where you take a disease space where there’s no known causality and then you apply technology to understand what is it actually that’s going on here? And having had years of experience in doing that with all the immunity was really what allowed for us to so first get results with the COVID long hauls. And I think that’s, to your point around what is the challenges we’ve going to be seeing in the healthcare system. It’s not necessarily going to be more medicine or other or all by there’s probably lots of great things that can be developed over the years. What I see as our biggest challenge is that behavior health has not been something that we’ve ever really trained doctors in doing. And so how do we bridge that gap because people are being sick from things they do between doctors’ visits and it’s hard to manage that expectation in short visits.

Dr. Jeff Bland:

Yeah. I really want to, again, just admire and acknowledge what you’re saying. I think it is so powerful that often we try to seek out a simple answer to complex questions and we then reduce that question down to a point where the answer is simple, but not right. And this pharmacotherapy model that we’ve had, which is one drug for one disease, that’s kind of the way that modern pharmacology emerged out of the age of antibiotics. We have a specific bug that we’re infected with for which there is a specific molecule that will prevent it from growing without killing any other cells of the host. That is us. So that was the model that started this whole pharmacotherapy approach towards treatment of disease.

When we get the complexity of these immunological problems in which we don’t even actually know how that disease was caused, it may or may not have something to do with an organism, but it’s probably not just one causal factor. It’s not genetic and in fact there are very low linkages of our genes to autoimmune disease. So it’s a low penetrance of genetic risk. So then it’s a kind of a mystery of what its source is. It shows multiple symptoms on its outcome. It’s not a single symptom. And then we’re trying to treat it with one drug. Well, that just is not working. That model just does not work. And in fact, I think the pharmaceutical industry is starting to recognize it in some complex disorders like look at what’s happened with the treatment of hepatitis now. It wasn’t one drug, one molecule that treated. Now it’s a combination of molecules.

Similarly with HIV/AIDS, it’s a multiple portfolio of drugs and it’s not just one drug. So we’re starting to recognize these complex conditions where complex intervention. And there’s nothing more complex than lifestyle. We call it behavioral medicine or behavioral health and how do we adjust then that individual’s own decisions as to how they live, where they live and with whom they live in such a way that it will give their immune system the optimal opportunity to speak friendly to them and not be in a state of alarm, which is what we call autoimmunity. So I think that what you’re birthing here is conceptually a very, very different model than the one drug one disease model that many of us grew up in in our education.

Mette Dyhrberg:

No, that’s spot on, and thank you. Yeah, I think it’s, from my perspective as we are sort of taking this journey, I think we, from the very beginning, looked at this space thinking it’s 80% women, it’s women of color, it’s women of low wealth. It needs to be that we create something that’s affordable and scalable so that a rheumatoid doctor sitting somewhere can actually recommend it. And so from our perspective right now, most of our clients are self paid, which is obviously not where we would love to land, but when it comes to the payers, we can actually now see that out of the clients coming through Mymee, 33% stop to taking specialty pharma medication.

And initially, we were getting some pushback around like what are you doing? And we were like we are not a physician practice. We do not touch medication. If anyone talks about medication, they’re referred to their physicians. It is not our space. But it makes sense because even after you’re diagnosed, medication fails three out of four. So if you are taking medication and have no other alternative, you’re probably going to continue taking it. But if at some point you feel better, your blood work normalizes, your symptoms go away, of course your doctor’s going to take you off something that doesn’t work. The reality is that today we are basically throwing these blanket solutions onto a problem because it’s all we have. And so I think what becomes interesting in the future is when we start actually acknowledging that we can’t afford to look at the world through that lens anymore.

We had one, in our parents’ generation, one in 400 was by this condition. In ours, it’s one in five. And if you just pause there, there’s something completely wrong in one generation going from that magnitude to one in five. And that’s before we start counting the spike that will be coming as a result of COVID life. We all know that viruses and infections have been the largest trigger of autoimmunity, but we’ve never had a situation where it was 100 million Americans that got infected simultaneously. And as much as it sort of informs the geek in us for research purposes, it’s a human tragedy and we need to have a lot of compassion for those that are impacted. It’s terrifying to be in a position where you wake up one day and then the world as you know it is no longer standing. And so when we started working with COVID, it was actually an interesting little anecdote, but we always draw baseline, of course.

And when you look at the baseline symptomology of an autoimmune patient, and then a COVID long hauler, it’s almost 100% overlap in symptomology, but the severity of a COVID long hauler was like triple. And we were a little bit cautious and, oh, are we getting into something that might be out of our hands here? But we very quickly realized was that the autoimmune patients had been slow boiling, sort of like that frog analogy where you get thrown into cold water versus hot water, but they had been slow boiling for a couple of decades. So they had gotten used to it. Whereas the COVID long hauler had gotten all of the symptoms literally overnight and so they couldn’t manage their disease. They were so, so overwhelmed by every single symptom.

But as you actually sort of calmed that response down, they were exactly the same. It was just the perceived feeling of where they were that was so different. And it really is one of the things that I think is most fascinating about healthcare in the years to come is we faked very poor reporting. Poor reporting. To your point around the woman who wanted to cook and so on, we had a client once that she was on 27 drugs, she could work four hours at a time at Walmart, only a couple of shifts a week. She was the breadwinner of her family. Her life was really not ideal in any way, form, or shape. She ended up after this, I think she was only 12 weeks in when she got a full-time job. So now she could provide for her family, she was able to pick up her kids which she had never been able to do despite them actually having a progressed age. She completely had a turnaround: do her laundry, go down the street and do her girlfriend’s laundry.

And I thought this is going to be the best test case ever. And she had a 38% increase in physical activity. And I saw that number and I just got so angry. And my medical team was like Mette, this is an amazing improvement. I’m like are you kidding me? She had had like 220% improvement in her quality of life, but the way that these metrics are is if you’ve been sick for 10 years, you’re never going to tick that box of never because just three months ago, you remember it still. So I think that where technology becomes the most interesting across all of health care is when we can start getting a much more nuanced picture. For our perspective, one of the biggest things that I’m still horrified at today is we used to have a patient population we called non-compliant. Today, we compassionately call them brain fog. We didn’t even think about the fact.

Dr. Jeff Bland:


Mette Dyhrberg:

The reason they couldn’t do what they were supposed to do was because they didn’t even know how to name their husband right.

Dr. Jeff Bland:


Mette Dyhrberg:

So doing was analyzing text patterns so that we can see is this someone who’s struggling at that level where we can’t ask them to do the basics? And then you can pair it back and get them to a place where you can sort of overcome that hurdle before you get into the next portion. But I think that’s where we really need and I know we all talk about these digital biomarkers, but I think those biomarkers is going to be what’s going to be game changing more than anything else we are going to do in the coming years.

Dr. Jeff Bland:

I think you just so beautifully articulated your genius and how that has guided and informed the development of Mymee. That was absolutely brilliant, what you just said. And I’m, as you’re speaking, I’m reminded of the alternative approach, the pharmaceutical approach to autoimmune disease in which the drugs that are used generally to these diseases are immunosuppressive drugs. What they do is they put a blanket over the immune system. And there are places obviously where the symptoms will be significantly improved, but it also opens up the risk that your immune system is now so suppressed that you are now susceptible to things that normally your immune system would fight off. And so now you see black box warnings on these drugs like you might get TB or you might get lymphoma even as a consequence of your immune system being suppressed.

And then I ask the question, okay, what do we know about the clinical outcome of these drugs that are used to manage these complex autoimmune? And the way that we study outcome is we say what’s the intent to treat, how many people, what is the number that you need to treat to get a really positive outcome? And when I started looking at that, I was actually very disillusioned because it turns out that the number to treat to get a positive outcome in these highly expensive, sometimes these biologics for the treatment of autoimmune disease are tens of thousands of dollars of treatment cost. And if you look at the number of patients you have to treat to get a really positive outcome, it could be as many as 15 patients. Fifteen people with that diagnosis to get one really positive outcome.

Now, how do you know if you’re one of the people that got a positive outcome or not and whether that money is well spent for your treatment versus something that might be able to be much less expensive would actually get you engaged in your own healing of your immune system and would not suppress your system and lead you to a positive outcome? And that’s what you’re really speaking to is this different model that you’ve incorporated within Mymee. So I just want to applaud and thank you for your pioneering work and your colleagues and how this is opening up a thought process, not just only an approach, but a thought process about how we met these complex conditions that are associated with a changing environment we’re now living in, a changing social structure and how we’re going to deal with those without just finding the drug of the week to try to treat the symptoms, but look at the upstream ways that we can manage a person’s life to become a friend with their own immune system.

And I think that’s what you’re pioneering. And I have a great amount of respect for what you’ve done. So on behalf of all of our Big Bold Health podcast viewers and the many, many thousands of people that you’re positive;y impacting their quality of life, thanks so much for sharing this extraordinary story with us today.

Mette Dyhrberg:

Thank you so much, Jeff. Always a pleasure.

Dr. Jeff Bland:

You be well.

Mette Dyhrberg:

Thank you.

Also available on:

Apple Podcasts

Google Play



Medical Disclaimer






Terms of Service

Date Effective: March 2019




This website (the “Site”) is owned and operated by BIG BOLD HEALTH LLC(“COMPANY” “we” or “us”). By using the Site, you agree to be bound by these Terms of Service and to use the Site in accordance with these Terms of Service, our Privacy Policy, our Shipping Policy, our Return Policy and any additional terms and conditions that may apply to specific sections of the Site or to products and services available through the Site or from COMPANY. Accessing the Site, in any manner, whether automated or otherwise, constitutes use of the Site and your agreement to be bound by these Terms of Service.


We reserve the right to change these Terms of Service or to impose new conditions on use of the Site, from time to time, in which case we will post the revised Terms of Service on this website. By continuing to use the Site after we post any such changes, you accept the Terms of Service, as modified.


Intellectual Property Rights


Our Limited License to You. This Site and all the materials available on the Site are the property of us and/or our affiliates or licensors, and are protected by copyright, trademark, and other intellectual property laws. The Site is provided solely for your personal noncommercial use. You may not use the Site or the materials available on the Site in a manner that constitutes an infringement of our rights or that has not been authorized by us. More specifically, unless explicitly authorized in these Terms of Service or by the owner of the materials, you may not modify, copy, reproduce, republish, upload, post, transmit, translate, sell, create derivative works, exploit, or distribute in any manner or medium (including by email or other electronic means) any material from the Site. You may, however, from time to time, download and/or print one copy of individual pages of the Site for your personal, non-commercial use, provided that you keep intact all copyright and other proprietary notices.


Your License to Us. By posting or submitting any material (including, without limitation, comments, blog entries, Facebook postings, photos and videos) to us via the Site, internet groups, social media venues, or to any of our staff via email, text or otherwise, you are representing: (i) that you are the owner of the material, or are making your posting or submission with the express consent of the owner of the material; and (ii) that you are thirteen years of age or older. In addition, when you submit, email, text or deliver or post any material, you are granting us, and anyone authorized by us, a royalty-free, perpetual, irrevocable, non-exclusive, unrestricted, worldwide license to use, copy, modify, transmit, sell, exploit, create derivative works from, distribute, and/or publicly perform or display such material, in whole or in part, in any manner or medium, now known or hereafter developed, for any purpose. The foregoing grant shall include the right to exploit any proprietary rights in such posting or submission, including, but not limited to, rights under copyright, trademark, service mark or patent laws under any relevant jurisdiction. Also, in connection with the exercise of such rights, you grant us, and anyone authorized by us, the right to identify you as the author of any of your postings or submissions by name, email address or screen name, as we deem appropriate.


You acknowledge and agree that any contributions originally created by you for  us shall be deemed a “work made for hire” when the work performed is within the scope of the definition of a work made for hire in Section 101 of the United States Copyright Law, as amended.  As such, the copyrights in those works shall belong to COMPANY from their creation.  Thus, COMPANY shall be deemed the author and exclusive owner thereof and shall have the right to exploit any or all of the results and proceeds in any and all media, now known or hereafter devised, throughout the universe, in perpetuity, in all languages, as COMPANY determines.  In the event that any of the results and proceeds of your submissions hereunder are not deemed a “work made for hire” under Section 101 of the Copyright Act, as amended, you hereby, without additional compensation, irrevocably assign, convey and transfer to COMPANY all proprietary rights, including without limitation, all copyrights and trademarks throughout the universe, in perpetuity in every medium, whether now known or hereafter devised, to such material and any and all right, title and interest in and to all such proprietary rights in every medium, whether now known or hereafter devised, throughout the universe, in perpetuity. Any posted material which are reproductions of prior works by you shall be co-owned by us. 


You acknowledge that COMPANY has the right but not the obligation to use and display any postings or contributions of any kind and that COMPANY may elect to cease the use and display of any such materials (or any portion thereof), at any time for any reason whatsoever.


Limitations on Linking and Framing. You may establish a hypertext link to the Site so long as the link does not state or imply any sponsorship of your site by us or by the Site. However, you may not, without our prior written permission, frame or inline link any of the content of the Site, or incorporate into another website or other service any of our material, content or intellectual property.




Throughout the Site, we may provide links and pointers to Internet sites maintained by third parties. Our linking to such third-party sites does not imply an endorsement or sponsorship of such sites, or the information, products or services offered on or through the sites. In addition, neither we nor affiliates operate or control in any respect any information, products or services that third parties may provide on or through the Site or on websites linked to by us on the Site.


If applicable, any opinions, advice, statements, services, offers, or other information or content expressed or made available by third parties, including information providers, are those of the respective authors or distributors, and not COMPANY. Neither COMPANY nor any third-party provider of information guarantees the accuracy, completeness, or usefulness of any content. Furthermore, COMPANY neither endorses nor is responsible for the accuracy and reliability of any opinion, advice, or statement made on any of the Sites by anyone other than an authorized COMPANY representative while acting in his/her official capacity.






You agree at all times to defend, indemnify and hold harmless COMPANY its affiliates, their successors, transferees, assignees and licensees and their respective parent and subsidiary companies, agents, associates, officers, directors, shareholders and employees of each from and against any and all claims, causes of action, damages, liabilities, costs and expenses, including legal fees and expenses, arising out of or related to your breach of any obligation, warranty, representation or covenant  set forth herein.


Online Commerce


Certain sections of the Site may allow you to purchase many different types of products and services online that are provided by third parties. We are not responsible for the quality, accuracy, timeliness, reliability or any other aspect of these products and services. If you make a purchase from a merchant on the Site or on a site linked to by the Site, the information obtained during your visit to that merchant’s online store or site, and the information that you give as part of the transaction, such as your credit card number and contact information, may be collected by both the merchant and us. A merchant may have privacy and data collection practices that are different from ours. We have no responsibility or liability for these independent policies. In addition, when you purchase products or services on or through the Site, you may be subject to additional terms and conditions that specifically apply to your purchase or use of such products or services. For more information regarding a merchant, its online store, its privacy policies, and/or any additional terms and conditions that may apply, visit that merchant’s website and click on its information links or contact the merchant directly. You release us and our affiliates from any damages that you incur, and agree not to assert any claims against us or them, arising from your purchase or use of any products or services made available by third parties through the Site.


Your participation, correspondence or business dealings with any third party found on or through our Site, regarding payment and delivery of specific goods and services, and any other terms, conditions, representations or warranties associated with such dealings, are solely between you and such third party. You agree that COMPANY shall not be responsible or liable for any loss, damage, or other matters of any sort incurred as the result of such dealings.


You agree to be financially responsible for all purchases made by you or someone acting on your behalf through the Site. You agree to use the Site and to purchase services or products through the Site for legitimate, non-commercial purposes only. You also agree not to make any purchases for speculative, false or fraudulent purposes or for the purpose of anticipating demand for a particular product or service. You agree to only purchase goods or services for yourself or for another person for whom you are legally permitted to do so. When making a purchase for a third party that requires you to submit the third party’s personal information to us or a merchant, you represent that you have obtained the express consent of such third party to provide such third party’s personal information.


Interactive Features


This Site may include a variety of features, such as bulletin boards, web logs, chat rooms, and email services, which allow feedback to us and real-time interaction between users, and other features which allow users to communicate with others. Responsibility for what is posted on bulletin boards, web logs, chat rooms, and other public posting areas on the Site, or sent via any email services on the Site, lies with each user – you alone are responsible for the material you post or send. We do not control the messages, information or files that you or others may provide through the Site. It is a condition of your use of the Site that you do not:

  • Restrict or inhibit any other user from using and enjoying the Site.
  • Use the Site to impersonate any person or entity, or falsely state or otherwise misrepresent your affiliation with a person or entity.
  • Interfere with or disrupt any servers or networks used to provide the Site or its features, or disobey any requirements, procedures, policies or regulations of the networks we use to provide the Site.
  • Use the Site to instigate or encourage others to commit illegal activities or cause injury or property damage to any person.
  • Gain unauthorized access to the Site, or any account, computer system, or network connected to this Site, by means such as hacking, password mining or other illicit means.
  • Obtain or attempt to obtain any materials or information through any means not intentionally made available through this Site.
  • Use the Site to post or transmit any unlawful, threatening, abusive, libelous, defamatory, obscene, vulgar, pornographic, profane or indecent information of any kind, including without limitation any transmissions constituting or encouraging conduct that would constitute a criminal offense, give rise to civil liability or otherwise violate any local, state, national or international law.
  • Use the Site to post or transmit any information, software or other material that violates or infringes upon the rights of others, including material that is an invasion of privacy or publicity rights or that is protected by copyright, trademark or other proprietary right, or derivative works with respect thereto, without first obtaining permission from the owner or rights holder.
  • Use the Site to post or transmit any information, software or other material that contains a virus or other harmful component.
  • Use the Site to post, transmit or in any way exploit any information, software or other material for commercial purposes, or that contains advertising.
  • Use the Site to advertise or solicit to anyone to buy or sell products or services, or to make donations of any kind, without our express written approval.
  • Gather for marketing purposes any email addresses or other personal information that has been posted by other users of the Site.

COMPANY may host message boards, chats and other private/public forums on its Sites and on other platforms. Any user failing to comply with the terms and conditions of this Agreement may be expelled from and refused continued access to, the message boards, groups, chats or other such forums in the future. COMPANY or its designated agents may remove or alter any user-created content at any time for any reason. Message boards, chats and other public forums are intended to serve as discussion centers for users and subscribers. Information and content posted within these public forums may be provided by COMPANY staff, COMPANY’s outside contributors, or by users not connected with COMPANY, some of whom may employ anonymous user names. COMPANY expressly disclaims all responsibility and endorsement and makes no representation as to the validity of any opinion, advice, information or statement made or displayed in these forums by third parties, nor are we responsible for any errors or omissions in such postings, or for hyperlinks embedded in any messages. Under no circumstances will we, our affiliates, suppliers or agents be liable for any loss or damage caused by your reliance on information obtained through these forums. The opinions expressed in these forums are solely the opinions of the participants, and do not reflect the opinions of COMPANY or any of its subsidiaries or affiliates.


COMPANY has no obligation whatsoever to monitor any of the content or postings on the message boards, chat rooms or other public forums on the Sites. However, you acknowledge and agree that we have the absolute right to monitor the same at our sole discretion. In addition, we reserve the right to alter, edit, refuse to post or remove any postings or content, in whole or in part, for any reason and to disclose such materials and the circumstances surrounding their transmission to any third party in order to satisfy any applicable law, regulation, legal process or governmental request and to protect ourselves, our clients, sponsors, users and visitors.




To access certain features of the Site, we may ask you to provide certain demographic information including your gender, year of birth, zip code and country. In addition, if you elect to sign-up for a particular feature of the Site, such as chat rooms, web logs, or bulletin boards, you may also be asked to register with us on the form provided and such registration may require you to provide personally identifiable information such as your name and email address. You agree to provide true, accurate, current and complete information about yourself as prompted by the Site’s registration form. If we have reasonable grounds to suspect that such information is untrue, inaccurate, or incomplete, we have the right to suspend or terminate your account and refuse any and all current or future use of the Site (or any portion thereof). Our use of any personally identifiable information you provide to us as part of the registration process is governed by the terms of our Privacy Policy.




To use certain features of the Site, you will need a username and password, which you will receive through the Site’s registration process. You are responsible for maintaining the confidentiality of the password and account, and are responsible for all activities (whether by you or by others) that occur under your password or account. You agree to notify us immediately of any unauthorized use of your password or account or any other breach of security, and to ensure that you exit from your account at the end of each session. We cannot and will not be liable for any loss or damage arising from your failure to protect your password or account information.


Limitation of Liability













We may cancel or terminate your right to use the Site or any part of the Site at any time without notice. In the event of cancellation or termination, you are no longer authorized to access the part of the Site affected by such cancellation or termination. The restrictions imposed on you with respect to material downloaded from the Site, and the disclaimers and limitations of liabilities set forth in these Terms of Service, shall survive.


Refund Policy


Your purchase of a product or service or ticket to an event may or may not provide for any refund.  Each specific product, service, event or course will specify its own refund policy.


Digital Millennium Copyright Act


The Digital Millennium Copyright Act of 1998 (the “DMCA”) provides recourse for copyright owners who believe that material appearing on the Internet infringes their rights under the U.S. copyright law. If you believe in good faith that materials hosted by COMPANY infringe your copyright, you, or your agent may send to COMPANY a notice requesting that the material be removed or access to it be blocked. Any notification by a copyright owner or a person authorized to act on its behalf that fails to comply with requirements of the DMCA shall not be considered sufficient notice and shall not be deemed to confer upon COMPANY actual knowledge of facts or circumstances from which infringing material or acts are evident. If you believe in good faith that a notice of copyright infringement has been wrongly filed against you, the DMCA permits you to send to COMPANY a counter-notice. All notices and counter notices must meet the then current statutory requirements imposed by the DMCA; see for details. COMPANY’s Copyright Agent for notice shall be




This Agreement shall be binding upon and inure to the benefit of COMPANY and our respective assigns, successors, heirs, and legal representatives. Neither this Agreement nor any rights hereunder may be assigned without the prior written consent of COMPANY Notwithstanding the foregoing, all rights and obligations under this Agreement may be freely assigned by COMPANY to any affiliated entity or any of its wholly owned subsidiaries.


Dispute Resolution

These Terms of Use shall be governed by and construed in accordance with the laws of the State of Washington and any dispute shall be subject to binding arbitration in Bainbridge Island, Washington. If any provision of this agreement shall be unlawful, void or for any reason unenforceable, then that provision shall be deemed severable from this agreement and shall not affect the validity and enforceability of any remaining provisions.


Class Action Waiver


You may only resolve disputes with us on an individual basis, and may not bring a claim as a plaintiff or a class member in a class, consolidated, or representative action. Class arbitrations, class actions, private attorney general actions, and consolidation with other arbitrations aren’t allowed.


The arbitrator may not consolidate more than one person’s claims, and may not otherwise preside over any form of a class or representative proceeding or claims (such as a class action, consolidated action or private attorney general action) unless all relevant parties specifically agree to do so following initiation of the arbitration.




If any clause within these Terms of Service (other than the Class Action Waiver clause above) is found to be illegal or unenforceable, that clause will be severed from these Terms of Service, and the remainder of these Terms of Service will be given full force and effect. If the Class Action Waiver clause is found to be illegal or unenforceable, this entire Provision will be unenforceable and the dispute will be decided by a court.

Privacy Policy

Effective Date: March 2019


The following Privacy Policy governs the online information collection practices of BIG BOLD HEALTH LLC (“COMPANY,” “we” or “us”). Specifically, it outlines the types of information that we gather about you while you are using the website (the “Site”), and the ways in which we use this information. This Privacy Policy, including our children’s privacy statement, does not apply to any information you may provide to us or that we may collect offline and/or through other means (for example, at a live event, via telephone, or through the mail).


Please read this Privacy Policy carefully. By visiting and using the Site, you agree that your use of our Site, and any dispute over privacy, is governed by this Privacy Policy. Because the Web is an evolving medium, we may need to change our Privacy Policy at some point in the future, in which case we’ll post the changes to this Privacy Policy on this website and update the Effective Date of the policy to reflect the date of the changes. By continuing to use the Site after we post any such changes, you accept the Privacy Policy as modified.


How We Collect and Use Information


We may collect and store personal or other information that you voluntarily supply to us online while using the Site (e.g., while on the Site or in responding via email to a feature provided on the Site). The Site only contacts individuals who specifically request that we do so or in the event that they have signed up to receive our messaging, attended one of our events, or have purchased one of our products. The Site collects personally identifying information from our users during online registration and online purchasing. Generally, this information includes name and e-mail address for registration or opt-in purposes and name, postal address, and credit card information when registering for our events or purchasing our products. All of this information is provided to us by you.


We also collect and store information that is generated automatically as you navigate online through the Site. For example, we may collect information about your computer’s connection to the Internet, which allows us, among other things, to improve the delivery of our web pages to you and to measure traffic on the Site. We also may use a standard feature found in browser software called a “cookie” to enhance your experience with the Site. Cookies are small files that your web browser places on your hard drive for record-keeping purposes. By showing how and when visitors use the Site, cookies help us deliver advertisements, identify how many unique users visit us, and track user trends and patterns. They also prevent you from having to re-enter your preferences on certain areas of the Site where you may have entered preference information before. The Site also may use web beacons (single-pixel graphic files also known as “transparent GIFs”) to access cookies and to count users who visit the Site or open HTML-formatted email messages.


We use the information we collect from you while you are using the Site in a variety of ways, including using the information to customize features; advertising that appear on the Site; and, making other offers available to you via email, direct mail or otherwise. We also may provide your information to third parties, such as service providers, contractors and third-party publishers and advertisers for a variety of purposes. Unless you inform us in accordance with the process described below, we reserve the right to use, and to disclose to third parties, all of the information collected from and about you while you are using the Site in any way and for any purpose, such as to enable us or a third party to provide you with information about products and services. If you do not wish your information to be used for these purposes, you must send a letter to the Online Privacy Coordinator whose address is listed at the end of this Privacy Policy requesting to be taken off any lists of information that may be used for these purposes or that may be given or sold to third-parties.


Please keep in mind that whenever you voluntarily make your personal information available for viewing by third parties online – for example on message boards, web logs, through email, or in chat areas – that information can be seen, collected and used by others besides us. We cannot be responsible for any unauthorized third-party use of such information.


Some of our third-party advertisers and ad servers that place and present advertising on the Site also may collect information from you via cookies, web beacons or similar technologies. These third-party advertisers and ad servers may use the information they collect to help present their advertisements, to help measure and research the advertisements’ effectiveness, or for other purposes. The use and collection of your information by these third-party advertisers and ad servers is governed by the relevant third-party’s privacy policy and is not covered by our Privacy Policy. Indeed, the privacy policies of these third-party advertisers and ad servers may be different from ours. If you have any concerns about a third party’s use of cookies or web beacons or use of your information, you should visit that party’s website and review its privacy policy.

The Site also includes links to other websites and provides access to products and services offered by third parties, whose privacy policies we do not control. When you access another website or purchase third-party products or services through the Site, use of any information you provide is governed by the privacy policy of the operator of the site you are visiting or the provider of such products or services.


We may also make some content, products and services available through our Site or by emailing messages to you through cooperative relationships with third-party providers, where the brands of our provider partner appear on the Site in connection with such content, products and/or services. We may share with our provider partner any information you provide, or that is collected, in the course of visiting any pages that are made available in cooperation with our provider partner. In some cases, the provider partner may collect information from you directly, in which cases the privacy policy of our provider partner may apply to the provider partner’s use of your information. The privacy policy of our provider partners may differ from ours. If you have any questions regarding the privacy policy of one of our provider partners, you should contact the provider partner directly for more information.


Be aware that we may occasionally release information about our visitors when release is appropriate to comply with law or to protect the rights, property or safety of users of the Site or the public.


Please also note that as our business grows, we may buy or sell various assets. In the unlikely event that we sell some or all of our assets, or one or more of our websites is acquired by another company, information about our users may be among the transferred assets.


Google Analytics


We also use Google Analytics Advertiser Features to optimize our business. Advertiser features include:

  • Remarketing with Google Analytics
  • Google Display Network Impression Reporting
  • DoubleClick Platform integrations
  • Google Analytics Demographics and Interest Reporting

By enabling these Google Analytics Display features, we are required to notify our visitors by disclosing the use of these features and that we and third-party vendors use first-party cookies (such as the Google Analytics cookie) or other first-party identifiers, and third-party cookies (such as the DoubleClick cookie) or other third-party identifiers together to gather data about your activities on our Site.  Among other uses, this allows us to contact you if you begin to fill out our check-out form but abandon it before completion with an email reminding you to complete your order.  The “Remarketing” feature allows us to reach people who previously visited our Site, and match the right audience with the right advertising message.

You can opt out of Google’s use of cookies by visiting Google’s ad settings and/or you may opt out of a third-party vendor’s use of cookies by visiting the Network Advertising Initiative opt-out page.




As advertisers on Facebook and through our Facebook page, we, (not Facebook) may collect content or information from a Facebook user and such information may be used in the same manner specified in this Privacy Policy. You consent to our collection of such information.


We abide by Facebook’s Data Use Restrictions.

  • Any ad data collected, received or derived from our Facebook ad (“Facebook advertising data”) is only shared with someone acting on our behalf, such as our service provider. We are responsible for ensuring that our service providers protect any Facebook advertising data or any other information obtained from us, limit our use of all of that information, and keep it confidential and secure.
  • We do not use Facebook advertising data for any purpose (including retargeting, commingling data across multiple advertisers’ campaigns, or allowing piggybacking or redirecting with tags), except on an aggregate and anonymous basis (unless authorized by Facebook) and only to assess the performance and effectiveness of our Facebook advertising campaigns.
  • We do not use Facebook advertising data, including the targeting criteria for a Facebook ad, to build, append to, edit, influence, or augment user profiles, including profiles associated with any mobile device identifier or other unique identifier that identifies any particular user, browser, computer or device.
  • We do not transfer any Facebook advertising data (including anonymous, aggregate, or derived data) to any ad network, ad exchange, data broker or other advertising or monetization related service.


General Data Privacy Regulation (GDPR)


The GDPR took effect on May 25, 2018, and is intended to protect the data of European Union (EU) citizens. 


As a company that markets its site, content, products and/or services online we do not specifically target our marketing to the EU or conduct business in or to the EU in any meaningful way. If the data that you provide to us in the course of your use of our site, content, products and/or services is governed by GDPR, we will abide by the relevant portions of the Regulation.


If you are a resident of the European Economic Area (EEA), or are accessing this site from within the EEA, you may have the right to request: access to, correction of, deletion of; portability of; and restriction or objection to processing, of your personal data, from us. This includes the “right to be forgotten.”


To make any of these requests, please contact our GDPR contact at


Children’s Privacy Statement


This children’s privacy statement explains our practices with respect to the online collection and use of personal information from children under the age of thirteen, and provides important information regarding their rights under federal law with respect to such information.

  • This Site is not directed to children under the age of thirteen and we do NOT knowingly collect personally identifiable information from children under the age of thirteen as part of the Site. We screen users who wish to provide personal information in order to prevent users under the age of thirteen from providing such information. If we become aware that we have inadvertently received personally identifiable information from a user under the age of thirteen as part of the Site, we will delete such information from our records. If we change our practices in the future, we will obtain prior, verifiable parental consent before collecting any personally identifiable information from children under the age of thirteen as part of the Site.
  • Because we do not collect any personally identifiable information from children under the age of thirteen as part of the Site, we also do NOT knowingly distribute such information to third parties.
  • We do NOT knowingly allow children under the age of thirteen to publicly post or otherwise distribute personally identifiable contact information through the Site.
  • Because we do not collect any personally identifiable information from children under the age of thirteen as part of the Site, we do NOT condition the participation of a child under thirteen in the Site’s online activities on providing personally identifiable information.

The HIPAA Privacy Rule


The US Department of Health and Human Services provides:  The HIPAA Privacy Rule establishes national standards to protect individuals’ medical records and other personal health information and applies to health plans, health care clearinghouses, and those health care providers that conduct certain health care transactions electronically.  The Rule requires appropriate safeguards to protect the privacy of personal health information, and sets limits and conditions on the uses and disclosures that may be made of such information without patient authorization. The Rule also gives patients rights over their health information, including rights to examine and obtain a copy of their health records, and to request corrections.”


You acknowledge that our operation of the Site does not constitute the practice of medicine, and specifically does not create a doctor-patient relationship between you and Dr. Jeffrey Bland, PhD (the “Doctor”).  The information provided on the Site is for educational purposes only. 


Notwithstanding the fact that the Site does not create a doctor-patient relationship between you and DOCTOR, our preservation of your personal health information shall be HIPAA compliant.


For purposes of this Privacy Policy, “patients” are those individuals who have secured the in-person services DOCTOR.  If you are a patient of DOCTOR, you will be provided with a copy of DOCTOR’s HIPAA Privacy Statement, which governs the information collection practices of patients’ personal information by DOCTOR.


How do we store your information?


Your information is stored at the list server that delivers the Site content and messaging. Your information can only be accessed by those who help manage those lists in order to deliver e-mail to those who would like to receive the Site material.


All of the messaging or emails that are sent to you by the Site include an unsubscribe link in them. You can remove yourself at any time from our mailing list by clicking on the unsubscribe link that can be found in every communicaiton that we send you.


Changes to this Policy


This policy may be changed at any time at our discretion. If we should update this policy, we will post the updates to this page on our Website.


Questions About this Policy


If you have any questions or concerns regarding our privacy policy please direct them to: